Related Experiment Video
Updated: Aug 2, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Miliaria profunda
1Department of Dermatology, University of Virginia Health Sciences Center, Charlottesville, USA.
Abstract:
Miliaria profunda is an uncommon but highly characteristic disorder that can be disabling. We describe a patient with miliaria profunda who responded to therapy with anhydrous lanolin and isotretinoin. Clinical features, pathogenesis, differential diagnosis, and therapy are reviewed.
Insights
Miliaria profunda, a rare and disabling skin condition, can be effectively treated with anhydrous lanolin and isotretinoin. This case study highlights a successful therapeutic approach for this distinctive disorder.
Area of Science:
- Dermatology
- Clinical Medicine
Background:
- Miliaria profunda is an uncommon but characteristic disorder.
- It can lead to significant disability for affected individuals.
Observation:
- A case of miliaria profunda is described.
- The patient experienced a positive response to treatment.
Findings:
- Successful therapy involved the use of anhydrous lanolin and isotretinoin.
- The patient's condition improved with this combined treatment approach.
Implications:
- This suggests a potential therapeutic strategy for managing miliaria profunda.
- Further research into the efficacy of anhydrous lanolin and isotretinoin for miliaria profunda is warranted.
More Related Videos
Related Concept Videos
Symbiosis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Bacterial Meningitis
Malaria
Giardiasis
Bacterial Meningitis I: Introduction

